Literature DB >> 19809538

Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.

Jennifer L St Sauver, Steven J Jacobsen.   

Abstract

Inflammation is a common finding in histologic prostate specimens obtained from aging men, and accumulating data suggest that inflammation may play an important role in the development of benign prostatic hyperplasia (BPH), and the development and progression of lower urinary tract symptoms (LUTS). Inflammatory processes may contribute to prostatic enlargement directly through stimulation of prostate growth, or, alternatively, through decreasing prostatic apoptosis. Additionally, inflammatory processes may impact other components of the urogenital tract, such as the bladder, and contribute to the LUTS that may be experienced both in the presence and in the absence of prostate enlargement. Current research therefore offers clues about converging inflammatory pathways which may be targeted to improve treatment of BPH and/or LUTS as well as identifying potential targets for prevention of these syndromes.

Entities:  

Year:  2008        PMID: 19809538      PMCID: PMC2757322          DOI: 10.1007/s11918-008-0011-5

Source DB:  PubMed          Journal:  Curr Prostate Rep        ISSN: 1544-1865


  57 in total

1.  Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.

Authors:  Jennifer L St Sauver; Debra J Jacobson; Cynthia J Girman; Michael M Lieber; Michaela E McGree; Steven J Jacobsen
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

2.  Role of chronic inflammation in the promotion of prostatic hyperplasia in rats.

Authors:  O J Kessler; Y Keisari; C Servadio; A Abramovici
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

3.  Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

Authors:  Franco Di Silverio; Cesare Bosman; Monti Salvatori; Luca Albanesi; Laura Proietti Pannunzi; Mauro Ciccariello; Antonio Cardi; Gianfilippo Salvatori; Alessandro Sciarra
Journal:  Eur Urol       Date:  2005-01       Impact factor: 20.096

4.  Urologic diseases in America project: benign prostatic hyperplasia.

Authors:  John T Wei; Elizabeth Calhoun; Steven J Jacobsen
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

5.  Evidence for the involvement of arachidonic acid metabolites in spontaneous and drug-induced contractions of rat urinary bladder.

Authors:  C A Maggi; S Evangelista; G Grimaldi; P Santicioli; A Giolitti; A Meli
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

6.  Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes.

Authors:  Patrizia Angelico; Luciano Guarneri; Cristina Velasco; Rita Cova; Amedeo Leonardi; David E Clarke; Rodolfo Testa
Journal:  BJU Int       Date:  2006-04       Impact factor: 5.588

7.  Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch.

Authors:  J M Park; T Yang; L J Arend; J B Schnermann; C A Peters; M R Freeman; J P Briggs
Journal:  Am J Physiol       Date:  1999-01

8.  Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

Authors:  Georg E Steiner; Martin E Newman; Doris Paikl; Ursula Stix; Nima Memaran-Dagda; Chung Lee; Michael J Marberger
Journal:  Prostate       Date:  2003-08-01       Impact factor: 4.104

9.  Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.

Authors:  S Meini; A Lecci; P Cucchi; R M Catalioto; M Criscuoli; C A Maggi
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

10.  Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping.

Authors:  Tohru Araki; Teruhiko Yokoyama; Hiromi Kumon
Journal:  Acta Med Okayama       Date:  2004-02       Impact factor: 0.892

View more
  19 in total

1.  Are statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey.

Authors:  Susan A Hall; Gretchen R Chiu; Carol L Link; William D Steers; Varant Kupelian; John B McKinlay
Journal:  Ann Epidemiol       Date:  2011-03       Impact factor: 3.797

2.  Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.

Authors:  Emma H Allott; Lauren E Howard; Adriana C Vidal; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal:  Cancer Prev Res (Phila)       Date:  2017-05-09

3.  Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey.

Authors:  Margaret A Gates; Susan A Hall; Gretchen R Chiu; Varant Kupelian; Mary P Fitzgerald; Carol L Link; John B McKinlay
Journal:  Am J Epidemiol       Date:  2011-02-28       Impact factor: 4.897

4.  Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men.

Authors:  Benjamin N Breyer; Eric Vittinghoff; Stephen K Van Den Eeden; Bradley A Erickson; Alan W Shindel
Journal:  Urology       Date:  2011-10-02       Impact factor: 2.649

5.  Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue.

Authors:  Zong-Lin Wu; Ya Yuan; He Geng; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2011-12-12       Impact factor: 3.285

Review 6.  Prostatic fibrosis, lower urinary tract symptoms, and BPH.

Authors:  Jose A Rodriguez-Nieves; Jill A Macoska
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

Review 7.  Diabetes and benign prostatic hyperplasia: emerging clinical connections.

Authors:  Aruna V Sarma; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

8.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

9.  Inflammatory Signaling Involved in High-Fat Diet Induced Prostate Diseases.

Authors:  Eswar Shankar; Natarajan Bhaskaran; Gregory T MacLennan; Guiming Liu; Firouz Daneshgari; Sanjay Gupta
Journal:  J Urol Res       Date:  2015-01-12

10.  Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.

Authors:  Reem T Atawia; Hala H Mosli; Mariane G Tadros; Amani E Khalifa; Hisham A Mosli; Ashraf B Abdel-Naim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-28       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.